Skip to the page

Data / Drug companies / Glenmark Therapeutics Inc., USA

Glenmark Therapeutics Inc., USA: 23 products in the FDA NDC directory, labeler code 72657

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Glenmark Therapeutics Inc., USA (labeler code 72657) lists 23 products in the FDA National Drug Code Directory, covering 12 finished drugs by generic name. By type: 23 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on November 1, 2026.

The request: Watch Glenmark Therapeutics Inc., USA (FDA labeler code 72657): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
72657
Products in commercial distribution
23
Packages
77
Finished drugs by generic name
12
Prescription products
0
Over the counter products
23
Flagged as original packager
19 of 19 products that carry the flag
Started marketing in the last 12 months
6
Earliest marketing start
June 1, 2022
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)1982.6%
Over the counter monograph drugs417.4%

Products by type

TypeProductsShare
Over the counter drugs23100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet, film coated417.4%
Tablet417.4%
Capsule, liquid filled417.4%
Spray, metered28.7%
Capsule, delayed release28.7%
Solution28.7%
Gel28.7%
Kit28.7%
Powder, for solution14.3%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Gas relief72657-482Capsule, liquid filledOver the counter monograph drugsNovember 1, 2026
Gas relief72657-481Capsule, liquid filledOver the counter monograph drugsNovember 1, 2026
Gas relief72657-480Capsule, liquid filledOver the counter monograph drugsNovember 1, 2026
Dextromethorphan Hydrobromide72657-484Capsule, liquid filledOver the counter monograph drugsOctober 1, 2026
Childrens Fluticasone Propionate ALLERGY RELIEF72657-166Spray, meteredGeneric drugs (ANDA)June 30, 2026
Fluticasone Propionate ALLERGY RELIEF72657-159Spray, meteredGeneric drugs (ANDA)March 16, 2026
Olopatadine hydrochloride72657-194SolutionGeneric drugs (ANDA)February 28, 2025
Famotidine72657-132Tablet, film coatedGeneric drugs (ANDA)October 8, 2024
Polyethylene Glycol 335072657-196Powder, for solutionGeneric drugs (ANDA)September 19, 2024
Olopatadine hydrochloride72657-168SolutionGeneric drugs (ANDA)July 26, 2024
Cetirizine HCl72657-131KitGeneric drugs (ANDA)May 13, 2024
Cetirizine HCl72657-130KitGeneric drugs (ANDA)May 13, 2024
Cetirizine HCl72657-129TabletGeneric drugs (ANDA)May 13, 2024
Cetirizine HCl72657-128TabletGeneric drugs (ANDA)May 13, 2024
Acetaminophen, Ibuprofen72657-157Tablet, film coatedGeneric drugs (ANDA)May 7, 2024
Esomeprazole magnesium72657-127Capsule, delayed releaseGeneric drugs (ANDA)August 22, 2023
Esomeprazole magnesium72657-124Capsule, delayed releaseGeneric drugs (ANDA)August 22, 2023
Adapalene72657-158GelGeneric drugs (ANDA)March 10, 2023
Adapalene72657-158GelGeneric drugs (ANDA)March 10, 2023
Levonorgestrel72657-123TabletGeneric drugs (ANDA)February 9, 2023
SheWise72657-108TabletGeneric drugs (ANDA)July 29, 2022
Famotidine72657-113Tablet, film coatedGeneric drugs (ANDA)June 1, 2022
Famotidine72657-112Tablet, film coatedGeneric drugs (ANDA)June 1, 2022

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.